Trendletter16 September 2020
The Trendlines Group Trendletter September 2020
” Analyst coverage for Trendlines…Six companies announce funding … Medical webinar open for registration …” Read more >
” Analyst coverage for Trendlines…Six companies announce funding … Medical webinar open for registration …” Read more >
Phytolon announced that it secured $4.1 million in funding for its fermentation-based technology for the production of plant-based food colors. Read more >
The Trendlines Group is pleased to announce investments in Arcuro Medical, FruitSpec, ProArc Medical and Phytolon. Read more >
Vessi Medical, a portfolio company of The Trendlines Group announced that it secured $1.7 million in funding for its cryoablation solution for superficial bladder cancer. Participating in the financing were Agriline, The Trendlines Group, the Israel Innovation Authority... Read more >
“Trendlines expands in Singapore and Shanghai … New funding for Phytolon and PregnanTech … Hargol FoodTech in international media” Read more >
Insectta is making leaps and bounds in food waste recycling work with their army of insects. Read more >
Trendlines Medical Shanghai partners with Chinese medical companies, governmental programs, and entrepreneurs to develop novel medical technologies for the Chinese and global markets. Read more >
From biblical plague to modern day protein, one Israeli firm wants to make locusts a sustainable food choice in the Holy Land and beyond. As for whether or not the insects are kosher, the answer is not so simple. Read more >
Trendlines Labs Singapore will invent and develop novel medical technologies, innovating and creating value for Trendlines’ portfolio companies and strategic partners Read more >
“Interview with Steve Rhodes… PregnanTech funding on ExitValley… Arcuro Medical and ST Stent launch sales” Read more >